- Home
- BPOP vs LEGN Comparison
BPOP vs LEGN Comparison
Compare BPOP & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPOP
- LEGN
- Stock Information
- Founded
- BPOP 1893
- LEGN 2014
- Country
- BPOP United States
- LEGN United States
- Employees
- BPOP N/A
- LEGN N/A
- Industry
- BPOP Major Banks
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- BPOP Finance
- LEGN Health Care
- Exchange
- BPOP Nasdaq
- LEGN Nasdaq
- Market Cap
- BPOP 7.8B
- LEGN 6.3B
- IPO Year
- BPOP N/A
- LEGN 2020
- Fundamental
- Price
- BPOP $114.42
- LEGN $32.02
- Analyst Decision
- BPOP Buy
- LEGN Strong Buy
- Analyst Count
- BPOP 8
- LEGN 12
- Target Price
- BPOP $132.75
- LEGN $70.82
- AVG Volume (30 Days)
- BPOP 575.5K
- LEGN 1.5M
- Earning Date
- BPOP 10-23-2025
- LEGN 11-11-2025
- Dividend Yield
- BPOP 2.64%
- LEGN N/A
- EPS Growth
- BPOP 53.22
- LEGN N/A
- EPS
- BPOP 11.28
- LEGN N/A
- Revenue
- BPOP $2,876,597,000.00
- LEGN $796,838,000.00
- Revenue This Year
- BPOP $0.07
- LEGN $70.27
- Revenue Next Year
- BPOP $8.00
- LEGN $50.28
- P/E Ratio
- BPOP $10.09
- LEGN N/A
- Revenue Growth
- BPOP 9.83
- LEGN 74.75
- 52 Week Low
- BPOP $78.23
- LEGN $27.34
- 52 Week High
- BPOP $129.32
- LEGN $47.79
- Technical
- Relative Strength Index (RSI)
- BPOP 38.06
- LEGN 43.58
- Support Level
- BPOP $110.81
- LEGN $31.60
- Resistance Level
- BPOP $119.66
- LEGN $33.09
- Average True Range (ATR)
- BPOP 4.09
- LEGN 1.48
- MACD
- BPOP -1.00
- LEGN 0.08
- Stochastic Oscillator
- BPOP 19.89
- LEGN 31.02
About BPOP Popular Inc.
Popular Inc, based in Puerto Rico, is a financial holding company with four main subsidiaries: Banco Popular de Puerto Rico, a bank in Puerto Rico in terms of assets; Banco Popular North America, its banking operation in the continental United States; Evertec, a data processor; and Popular Financial Holdings, a diversified financial services company. The Corporation's reportable segments consist of Banco Popular de Puerto Rico and Popular U.S.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.